T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
73 hedge funds and large institutions have $42.6M invested in T2 Biosystems, Inc in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 9 closing their positions.
133% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 9
59% more capital invested
Capital invested by funds: $26.7M → $42.6M (+$15.9M)
50% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 12
23% more call options, than puts
Call options by funds: $1.14M | Put options by funds: $926K
18% more funds holding
Funds holding: 62 → 73 (+11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.9M |
| 2 |
BlackRock
New York
|
+$1.69M |
| 3 |
Renaissance Technologies
New York
|
+$1.43M |
| 4 |
Two Sigma Investments
New York
|
+$1.41M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.56M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$604K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$339K |
| 4 |
LCS
Levin Capital Strategies
New York
|
-$265K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$196K |
TTOO Hedge Fund Activity: Q1 2021 in Review
73 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2021, worth a combined $42.6M — up 59% from $26.7M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new TTOO positions and 9 closed out — a net gain of 12 holders — while 18 added to existing stakes and 12 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.9M. The largest seller was Osaic Holdings, cutting an estimated $1.56M.
- 73 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2021, up from 62 in Q4 2020.
- Funds reported $42.6M of T2 Biosystems, Inc stock for Q1 2021, up 59% quarter-over-quarter.
- 21 funds opened new T2 Biosystems, Inc positions in Q1 2021 and 9 closed out, a net change of +12 holders.
- The largest T2 Biosystems, Inc buyer in Q1 2021 was Millennium Management, an estimated $2.9M added.
- The largest T2 Biosystems, Inc seller in Q1 2021 was Osaic Holdings, an estimated $1.56M sold.
Based on aggregated 13F filings for Q1 2021.